A composition of matter and method patent issued to UCSF will be used to generate new cancer therapies using modified immune cells via an exclusive license to one company. 

Cell Design Labs Announces Issuance Of Broad Patent For Programmable Car T Cells To Treat Cancer And Other Diseases
Share

Previous Post

Next Post

Be the first to comment.

Write a comment

2nd Annual Patexia Mixer

Our second Mixer will be on January 18th in Santa Monica. Make sure to Register Today

Menu

0.34160494804382